Initiative Neue Soziale Marktwirtschaft (Insm)

Initiative Neue Soziale Marktwirtschaft (Insm) company information, Employees & Contact Information

Die Initiative Neue Soziale Marktwirtschaft (INSM) ist eine regierungsunabhängige, branchen- und parteiübergreifende Organisation, die sich für fairen Wettbewerb, unternehmerische Freiheit, sozialen Ausgleich, Chancengerechtigkeit und eine verantwortungsvolle, generationengerechte Politik einsetzt. Sie wirbt für eine Politik, die sich an den Grundwerten der Sozialen Marktwirtschaft orientiert und macht deren praktische und theoretischen Grundlagen bekannter. Sie ist offen für alle, die sich dem Gedanken der Sozialen Marktwirtschaft verbunden fühlen. Die Arbeit der INSM wird von den Arbeitgeberverbänden der Metall- und Elektro-Industrie finanziert. Impressum: insm.de/impressum

Company Details

Employees
17
Founded
-
Address
Berlin, Berlin
Phone
+49 30 27877171
Email
in****@****insm.de
Industry
Political Organizations
NAICS
Business, Professional, Labor, Political, and Similar Organizations
Labor Unions and Similar Labor Organizations
Political Organizations
Other Similar Organizations (except Business, Professional, Labor, and Political Organizations)
Website
insm.de
HQ
Berlin, Berlin
Looking for a particular Initiative Neue Soziale Marktwirtschaft (Insm) employee's phone or email?

Initiative Neue Soziale Marktwirtschaft (Insm) Questions

News

Insmed (Nasdaq: INSM) named No. 1 biopharma employer by Science for fifth straight year - Stock Titan

Insmed (Nasdaq: INSM) named No. 1 biopharma employer by Science for fifth straight year Stock Titan

Insmed: De-Risked Respiratory Growth, Premium Multiple, And Real M&A Optionality - Seeking Alpha

Insmed: De-Risked Respiratory Growth, Premium Multiple, And Real M&A Optionality Seeking Alpha

This ‘Strong Buy’ Stock Is Trading at New 20-Year Highs - Yahoo Finance

This ‘Strong Buy’ Stock Is Trading at New 20-Year Highs Yahoo Finance

Q3 2025 Results on Oct. 30 — Insmed Schedules Investor Call; Live Webcast & Replay - Stock Titan

Q3 2025 Results on Oct. 30 — Insmed Schedules Investor Call; Live Webcast & Replay Stock Titan

Insmed Presents Six ASPEN Analyses, Late‑Breaking HRCT Results | INSM Stock News - Stock Titan

Insmed Presents Six ASPEN Analyses, Late‑Breaking HRCT Results | INSM Stock News Stock Titan

German Greens confirm Baerbock as chancellor candidate - DW

German Greens confirm Baerbock as chancellor candidate DW

First-in-Class BRINSUPRI: CHMP Recommends EU Approval for NCFB Patients 12+ (Insmed) — EMA review pending - Stock Titan

First-in-Class BRINSUPRI: CHMP Recommends EU Approval for NCFB Patients 12+ (Insmed) — EMA review pending Stock Titan

Pension at 63 – Quo vadis? - Prognos AG

Pension at 63 – Quo vadis? Prognos AG

German businesses warn against 'Dexit' amid fears of far-right gains - Euractiv

German businesses warn against 'Dexit' amid fears of far-right gains Euractiv

115 New Hires Receive $9.6M+ in Stock Awards: Insmed's Major Talent Investment Under NASDAQ Rules - Stock Titan

115 New Hires Receive $9.6M+ in Stock Awards: Insmed's Major Talent Investment Under NASDAQ Rules Stock Titan

Primary schools in Germany: a guide for expat parents - Expatica

Primary schools in Germany: a guide for expat parents Expatica

How do Germany's federal states compare on quality of education? - IamExpat in Germany

How do Germany's federal states compare on quality of education? IamExpat in Germany

Insmed Sets Q2 2025 Earnings Date: Biopharma Leader to Discuss Financial Results August 7 - Stock Titan

Insmed Sets Q2 2025 Earnings Date: Biopharma Leader to Discuss Financial Results August 7 Stock Titan

Saxony 'top' and Berlin 'flop' in new Germany-wide education rankings - The Local Germany

Saxony 'top' and Berlin 'flop' in new Germany-wide education rankings The Local Germany

Biotech Leader Insmed Announces Double-Header: Wells Fargo and Morgan Stanley Healthcare Conferences - Stock Titan

Biotech Leader Insmed Announces Double-Header: Wells Fargo and Morgan Stanley Healthcare Conferences Stock Titan

Insmed Announces Massive $650M Stock Offering with Goldman Sachs, Leerink as Underwriters - Stock Titan

Insmed Announces Massive $650M Stock Offering with Goldman Sachs, Leerink as Underwriters Stock Titan

Insmed CEO Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Expected - Stock Titan

Insmed CEO Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Expected Stock Titan

Late-Breaking PAH Treatment Data: Insmed's TPIP Phase 2b Results Lead 7 Presentations at ERS Congress 2025 - Stock Titan

Late-Breaking PAH Treatment Data: Insmed's TPIP Phase 2b Results Lead 7 Presentations at ERS Congress 2025 Stock Titan

FDA Makes History: First-Ever Treatment for 500,000 Non-Cystic Fibrosis Bronchiectasis Patients Gets Approval - Stock Titan

FDA Makes History: First-Ever Treatment for 500,000 Non-Cystic Fibrosis Bronchiectasis Patients Gets Approval Stock Titan

Top Initiative Neue Soziale Marktwirtschaft (Insm) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant